Back
Atossa Therapeutics 10K Form
Buy
53
ATOS
Atossa Therapeutics
Last Price:
$0.83
Seasonality Move:
-0.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATOS News And Ratings
See the #1 stock for the next 7 days that we like better than ATOS
ATOS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.51 |
| Price / Book: | 1.72 |
Profitability
| EPS (TTM): | -0.21000 |
|---|---|
| Net Income (TTM): | $-26.3M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Atossa Therapeutics Earnings Forecast
Key Atossa Therapeutics Financial Ratios
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Atossa Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATOS |
| CUSIP: | 04962H |
| Website: | atossatherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATOS Technical Analysis vs Fundamental Analysis
Buy
53
Atossa Therapeutics (ATOS)
is a Buy
Is Atossa Therapeutics a Buy or a Sell?
-
Atossa Therapeutics stock is rated a BuyThe current Atossa Therapeutics [ATOS] share price is $0.87. The Score for ATOS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.